{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:17:35Z","timestamp":1786987055714,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.clnu.2012.12.009","type":"journal-article","created":{"date-parts":[[2012,12,27]],"date-time":"2012-12-27T23:43:28Z","timestamp":1356651808000},"page":"722-727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: A meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"32","author":[{"given":"Xianhui","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanfan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2012.12.009_bib1","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2215\/CJN.05310610","article-title":"Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: a meta-analysis","volume":"6","author":"Qin","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clnu.2012.12.009_bib2","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1001\/jama.2010.490","article-title":"Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial","volume":"303","author":"House","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.clnu.2012.12.009_bib3","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.110.000588","article-title":"Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the folic Acid for vascular outcome reduction in transplantation trial","volume":"123","author":"Bostom","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.clnu.2012.12.009_bib4","doi-asserted-by":"crossref","first-page":"e3533","DOI":"10.1136\/bmj.e3533","article-title":"The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis","volume":"344","author":"Jardine","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.clnu.2012.12.009_bib5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clnu.2012.12.009_bib6","first-page":"PI19","article-title":"E\ufb00ects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients","volume":"9","author":"Righetti","year":"2003","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.clnu.2012.12.009_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000093680","article-title":"Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients","volume":"24","author":"Righetti","year":"2006","journal-title":"Blood Purif"},{"key":"10.1016\/j.clnu.2012.12.009_bib8","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jacc.2005.10.064","article-title":"Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial","volume":"47","author":"Zoungas","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clnu.2012.12.009_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1542-4758.2007.00171.x","article-title":"Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events","volume":"11","author":"Vianna","year":"2007","journal-title":"Hemodial Int"},{"key":"10.1016\/j.clnu.2012.12.009_bib10","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/CIRCULATIONAHA.109.904672","article-title":"B\u00a0vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial","volume":"121","author":"Heinz","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.clnu.2012.12.009_bib11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/01.ASN.0000110181.64655.6C","article-title":"Randomized trial of folic acid for prevention of cardiovascular events in end stage renal disease","volume":"15","author":"Wrone","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.clnu.2012.12.009_bib12","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","article-title":"Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end stage renal disease: a randomized controlled trial","volume":"298","author":"Jamison","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.clnu.2012.12.009_bib13","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.2010.840","article-title":"Effects of homocysteine-lowering with folic acid plus vitamin B12 vs. Placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial","volume":"303","author":"Armitage","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.clnu.2012.12.009_bib14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1474-4422(10)70187-3","article-title":"B\u00a0vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial","volume":"9","year":"2010","journal-title":"Lancet Neuro"},{"key":"10.1016\/j.clnu.2012.12.009_bib15","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ndt\/gfm485","article-title":"HOPE-2 investigators: homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease\u2013results of the renal Hope-2 study","volume":"23","author":"Mann","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clnu.2012.12.009_bib16","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/archinternmed.2010.348","article-title":"Effects of lowering homocysteine Levels with B Vitamins on cardiovascular disease, cancer, and cause-specific mortality meta-analysis of 8 randomized trials involving 37 485 individuals","volume":"170","author":"Clarke","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clnu.2012.12.009_bib17","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S1474-4422(12)70091-1","article-title":"Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial","volume":"11","author":"Hankey","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clnu.2012.12.009_bib18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1742-1241.2012.02929.x","article-title":"Efficacy of folic acid supplementation in stroke prevention: new insight from a meta-analysis","volume":"66","author":"Huo","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.clnu.2012.12.009_bib19","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ejim.2012.07.004","article-title":"Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials","volume":"23","author":"Yang","year":"2012","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.clnu.2012.12.009_bib20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/hq0102.102190","article-title":"Folates and cardiovascular disease","volume":"22","author":"Verhaar","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561412002804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561412002804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T17:01:42Z","timestamp":1539968502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561412002804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0261561412002804"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2012.12.009","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717976441.793471301","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717976441.793470822","asserted-by":"object"}]},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: A meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2012.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}